The tumor growth inhibition was AAV8-TR2-OriP-TK transduction and GCV administration specific because iSLK/KSHV cells without AAV8-TR2-OriP-TK planted in the same mice with GCV continued to grow. The gene discussed is TKT; the disease is neoplasm.